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ria which are based on our previous experience: stent in LAD, bail-out for
occlusion, major side branches within stented segment, adjacent stenoses
~50%, dissection not fully covered by stent, TIMII or II distal run-off, myocar-
dial infarction within the last two weeks, intracoronarythrombus, recanalized
chronic occlusions, minimal lumnial area within stent under 8 mm2 with in-
travascular ultrasound. 60 patients had less than two of these criteria, and
in a prospective trial were treated with heparin Lv. for 24 hours, and sub-
sequently received aspirin 200 mg/day and ticlopidin 500 mg/day (ambula-
tion after 36h). The final minimal lumen diameter achieved after stenting was
3.15 ± 0.55 mm (median 3.8% residual stenosis). Comparing the four-week
clinical follow-up of these patients with our previous experience in 301 pa-
tients all treated with coumadin, we saw no cardiac deaths (compared to
1.3%), no non-fatal myocardial infarction (3,9%), no subacute thrombotic
stent occlusions (6.9%), no need for repeat revascularization (PTCA orCABG)
of the stented vessel (7.3%); local vascular complications were seen in 1.7%
(30.2%), requiring surgery in none (5.6%), major bleeding not related to the
vascular access site occurred in 1.7% (9.0%). A six-month follow-up angiog-
raphy is scheduled.
Conclusions: Clinical, angiographic and ultrasound criteria allow the defini-
tion of a low-risk group of patients with stenting for progressive dissection.
Our data suggest that in these patients the risk for complications is substan-
tially decreased, and post-procedural anticoagulation is not required.
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1721-1 I Percutaneous Balloon Dilation as Initial Treatment for
Critical Aortic Stenosis. Results Up to 8.3 Years
Follow-up In 46 Consecutives Neonates
Eryberto S.T. Egilo, John F. Keane, Phillip Moore, John O'Sullivan, Sleven D. Colan,
Stanton B. Perry, James E. Lock. Children's Hospital, Boston, MA
The purpose of this study is to report our results with balloon dilation (BD) of
critical aortic stenosis (AS) in neonates. From 1985 to '91, 46 consecutive ba-
bies <33 days of age had BD for critical AS. The median age was 5 days, and
the mean weight was 3.2 kg; 41 (89%) was in congestive heart failure (CHF)
or shock, 33 (80%) intubated. Associated cardiac abnormalities were present
in 42 (91 %). The BD, performed retrograde in 43 (umbilical artery 23, femoral
artery 20), was completed in all, and with success in 41 (89%). The final bal-
loon to aortic annulus ratio was 0.91 ± 0.05. The overall mortality was 35%
(11 early and 5 late deaths 1.6 to 17 mos of follow-up). Of these 16, 4 were
considered related to BD, and 12 to associated left-sided lesions. All babies
who had BD via femoral artery had pulse loss, and anti-thrombotic therapy
restored pulses in 7 (35%). Significant aortic regurgitation (AR) post-BD was
observed in 5 (11 %) babies. An anatomic risk factor score for two-ventricle re-
pair(Rhodes et ai, 1991) was retrospectively measured, and 13 (38%) babies
had a score ~2 (critical AS with 2 or more associated left-sided obstructive le-
sions; high mortality). No neonate with an anatomic score ~2 survived longer
than 4 mos, except 1 who underwent successful Norwood operation. In uni-
variante analysis, an age of <3 days, a presentation in CHF or shock, and an
anatomic score ~2 were found to be related to mortality, but in a multivariante
analysis, only the anatomic score was significant (p = 0.001). Reintervention
was undertaken by 1 month in 22%, by 4 mos in 30%, and by 88 mos in 41 %;
the main indication was AS. At follow-up of 1.4 to 83 yrs (4.3 ± 1.8yrs), 30
(65%) were alive, and the clinical status was considered excellent or good in
90%. No child had leg length discrepancy. At Doppler study, a maximum gra-
dient >50 mmHg was found in 10 (33%), and significant AR was present in 4
(13%).
In conclusion, when no more than 1 associated left-sided obstructive le-
sion is present. BD for critical AS is effective; at 8.3 yrs of follow-up, the prob-
ability of being alive is 88%, and of being free from reintervention is 59%.
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1721-21 Aortic Valve Repair and Replacement After Balloon
Aortic Valvuloplasty In Children
John A. Hawkins, L. LuAnn Minich, Robert E. Shaddy, Lloyd Y. Tani, Jane
E. Sturtevant, Edwin C. McGough. Primary Children's Med Center and University of
Utah, Salt Lake City, UT
Little is known about the incidence, indications and results of surgical repair
or replacement of the aortic valve following balloon valvuloplasty for congeni-
tal aortic stenosis in children. This study was designed to evaluate patterns of
failure requiring surgery after balloon aortic valvuloplasty (BAli.) of congenital
AS and to review our experience with successful repair, rather than replace-
ment, of some aortic valves after BA\/. From 1986 to 1994, 54 patients with
congenital AS aged 1 day-27 years (mean ± sd; 8 ± 6 yrs) underwent BA\/.
Eighteen patients (33%) required surgery a mean of 33 ± 25 mos (range 1 to
80 mos) following BAli. because of severe AI in 10 patients and recurrent or
residual AS in 8 patients.
Severe AI was invariably due to avulsion of a cusp from the annulus with
resulting cusp prolapse and insufficiency. Actuarial freedom from surgical in-
tervention was 90 ± 4% at 1 year, 79 ± 6% at 3 years, and 64 ± 7% at 6 years.
The need for aortic valve surgery was unrelated to age at the time of BA\/.
Surgical intervention consisted of valve replacement in 11 patients and aor-
tic valve repair in 7 patients. Repair techniques included reattachment of an
avulsed cusp to the aortic annulus, relief of commissural fusion, and debride-
ment ofthickened cusps. All survived operation and are alive 23 ± mos (range
2-44 mos) following aortic valve operation. LV outflow gradient has been well
relieved in all patients undergoing valve replacement. The 7 valve repair pa-
tients have been followed 17 ± 10 mos (range 4-33 mos). Echocardiographic
follow-up of the valve repair patients revealed mild levels of residual AS and
mild (1-2+) AI in all patients.
Aortic valve surgery is required in 5-10% of patients yearly following BAli.
and appears to be unrelated to age at the time of BA\/. AI predominates over
AS as an indication for operative intervention. Valve repair can be applied in
some patients following BAli. with good intermediate-term results and may
delay the need for aortic valve replacement.
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1721-31 Five-to-Nine Year Follow-up Results of Balloon
Angioplasty of Native Aortic Coarctation
P. Syamasundar Rao, Omar Galal, Allen D. Wilson. Department of Pediatrics, Division
of Pediatric Cardiology, University of Wisconsin Medical School, University of Wisconsin
Children's Hospital, Madison, WI
Controversy exists with regard to the role of balloon angioplasty in the treat-
ment of native aortic coarctation. In an attempt to evaluate the usefulness of
this procedure we reviewed our experience with this procedure with a special
emphasis on follow-up results.
During an 8.7-year-period ending September 1993, 67 neonates, infants
and children underwent balloon angioplastywith resultant reduction in peak-
to-peak coarctation gradient from 48 ± 19(mean ± SD)to 11 ± 9 mmHg (P <
0.001). None required immediate surgical intervention. At intermediate-term
follow-up, catheterization (58 patients) and blood pressure (2 patients) data
revealed a residual gradient of 16 ± 15 mmHg. When individual results were
scrutinized 15 of 60 (25%) had recoarctation, defined as peak gradient >20
mmHg. Recoarctation was higher (P < 0.01) in neonates [5 of 6 (83%)] and
infants [7 of 18 (39%)] than in children [3 of 36 (8%)], respectively. Two infants
in our early experience had surgical resection with excellent results. Three pa-
tients had no discrete narrowing but had normal arm blood pressure and had
no intervention. The remaining 10 patients had repeat balloon angioplasty
with reduction of peak gradients from 52 ± 13 to 9 ± 8 mmHg (P < 0.001).
Reexamination 31 ± 18 months after repeat angioplasty revealed a residual
gradient of 3 to 19 (11 ± 6) mmHg. Three (5%) of 58 patients who under-
went follow-up angiography developed aneurysms. One child had a moder-
ate aneurysm and surgical resection was performed without difficulty. During
1 and 4 year follow-up, no further increase in the size of the aneurysm oc-
curred in the remaining two children.
Blood pressure, echo-Doppler and repeat angiographic or magnetic res-
onance imaging data 5 to 9 years after angioplasty revealed no new
aneurysms, normal blood pressures in 77% patients, and minimal (2%) late
recoarctation.
Based on these data it is concluded that balloon angioplasty is safe and ef-
fective in the treatment of native aortic coarctation; significant incidence of
recoarctation is seen in neonates and infants; repeat balloon angioplasty for
recoarctation is feasible and effective; 5 to 9 year follow-up is encouraging;
and the time has come to consider balloon angioplasty as a therapeutic pro-
cedure of choice for the treatment of native aortic coarctation.
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1721-41 Quantitative Echocardiographic Analysis of Aortic
Arch Morphometry Predicts Outcome of Balloon
Angioplasty of Native Coarctation of the Aorta
Stephen F. Kaine, E. O'8rian Smith, Charles E. Mullins, Tal Geva. Baylor College of
Medicine, Houston, Texas
To determine whether quantitative analysis of aortic arch morphometry can
predict outcome of balloon angioplasty(BA) of native coarctation of the aorta
(COA), we reviewed pre-angioplasty echocardiograms available on 105 pa-
tients undergoing BA from 1983-1994. Multiple aortic arch measures were
digitized off-line and indexed to BSA. Patients were categorized as angio-
plasty successes (residual systolic gradient <20 mmHg and freedom from in-
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tervention for recoarctation) or failures at immediate (0-1 mo.). intermediate
(1-72 mos.) and long-term (> 72 mos.) follow-up (FU) intervals. Comparisons
between categories of arch measures were performed for each FU interval.
Results: At immediate FU, the following differences between outcome cate-
gories were observed:
Echo Measurement Success (n = 83) Failure In = 22) Pvalue
Aortic Annulus (cm/BSAO.5) 1.48 ± 020 135 ± 023 <0.025
Distal Aortic Arch (cm/BSAO.5) 115±020 095 ± 0.17 <00001
Isthmus Icm/BSAO.5) 1.04 ± 0.17 0.79 ± 0.10 <00001
Isthmus z-score -1.14 ± 0.98 -2.61 ± 0.53 <00001
Isthmic Volume (ml/BSA1.5) 0.63 ± 0.35 0.30 ± 0.20 <0.0001
Coarctation Site (cm/BSAO.5) 054 ± 014 0.49 ± 0.10 NS
Isthmus/Descending Aorta 0.91 ± 0.18 0.68±014 <0.0001
At intermediate FU, the above variables achieved similar statistical signif-
icance in describing differences between success (n = 54) and failure (n =
21). Logistic regression ana~sis using isthmus z-score yielded a prediction
model P (Fail) = (1 +e-6.22- .39Z)-1 In the Immediate group. An Isthmus z-
score ~ -2.16 predicted failure (91 % sensitivity, 85% specificity). In the in-
termediate FU group, stepwise logistic regression with aortic annulus, isth-
mus z-score and coarctation sitelisthmus ratio yielded a model predicting
failure with 91 % sensitivity and 81 % specificity. Though less sensitive (39%),
echocardiographic presence of patent ductus arteriosus was a highly spe-
cific (93%) predictor of failure at immediate and intermediate FU, with posi-
tive predictive value of 81 %. A single patient failed during the long-term FU
interval. Conclusion: Quantitative echocardiographic analysis of aortic arch
morphometry predicts outcome of BA of native COA. These data may im-
prove selection of candidates for BA
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1721-51 Transcatheter Management of Pulmonary
Atresia/Intact Ventricular Septum (PA/IVS) in 29
Neonates
Jean-Franyois Piechaud, Jean Kachaner, Angelica Delogu, Laurence Iserin,
Yacine Aggoun, Daniel Sidi. Hopital Necker/Enfants-malades, Paris, France
Twenty-nine infants aged 1-14 days had a 'favorable' form of PA/IVS includ-
ing a well developed outflow tract separated from the pulmonary artery by
an imperforated membrane, a tricuspid annulus>7 mms in diameter and no
coronary fistulae. All had deep cyanosis and suprasystemic right ventricular
(RVI systolic pressure. They received intravenous prostaglandin (PGE1) and
undervvent transcatheter perforation of the membrane with a guide-wire, or
more recently (6 cases) with a radio-frequency probe, followed by balloon
dilation. In 6 cases (21 %), we failed to perforate or to dilate. In the other
23 (79%), the RV pressure fell dramatically with an outflow gradient <30
mmHg. Sixteen (70%) recovered an adequate antegrade RV flow while on
PGEl within 1-21 days (m = 8.7 ± 7.4). They are still doing well but 3 of them
had a residual infundibular stenosis which did not respond to redilation and
had to be operated on. Seven (30%1 did not improve despite awidely open RV
outflow tract and PGEl had to be replaced by a surgical shunt, with 2 deaths
and 510ng term recoveries. Non fatal complications included ductal injury (2).
myocardial perforation (1). necrotizing enterocolitis 12), sepsis (1).
In conclusion, owing to technical advances such as the use of radio-
frequency currents, relief of the outflow obstruction can be obtained in 80%
of the neonates with favorable forms of PAlIVS. As soon as the RV has recov-
ered its diastolicfunction, an adequateforvvard flow will appear. PGEl should
be infused in the meantime and surgery will be avoided in 61 % of the cases.
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PUlmonary Balloon Valvuloplasty: Effective Palliation
for Infants with Tetralogy of Fallot and Small
Pulmonary Arteries
Julie A Vincent, Ronald G. Grifka, Michael R. Nihill, Charles E. Mullins, Frank F. lng,
Cameron J. Ward. Texas Children's Hospital, Houston, Texas
Infants with tetralogy of Fallot (TOF) and small pulmonary arteries IPAs) may
need palliation to improve pulmonary blood flow and allow growth of the PAs
prior to complete repair. Shunts may become occluded, distort the PAs or
cause pulmonary overcirculation. As an alternative palliation, we performed
pulmonary balloon valvuloplasty (PBV) on infants with TOF and small PAs.
20 infants, ages 1.8 ± 1.5 mo and weights 4.1 ± 1.6 kg, undervvent PBV
as initial palliation for persistent cyanosis or "spells". 4120 pts were intubated
prior to or for PBV All pts had pre and post-PBV angiograms. In all pts, single
balloon valvuloplasty was performed. The ratio of balloon: pulmonary valve
annulus (PVA) diameter was 1.51 ± 0.32. Post-PBV, there was no change in
the PYA diameter (5.2 ± 1.1 mm vs 5.6 + 1.1 mm; p = 0.1) or PA branch di-
ameter(4.1 ± 1.6 mm vs 4.5 ± 1.7 mm, p > 0.05). The systemic 02 saturation
increased from 81 ± 8% to 93 ± 6%. (p < 0.001).
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7/20 pts undervvent follow-up (F/U) cath 8.2 ± 2.4 mo post-PBV Compared
to pre-PBV measurements, the PYA diameter increased from 5.2 ± 1.1 mm
to 7.1 ± 1.4 mm (p < 0.03) and the McGoon ratio increased from 1.4 ± 0.4 to
2.1 ± 0.3 (p < 0.02).
Of the 20 pts, 11 pts undervvent corrective surgery 8.0 ± 3.1 mo post-PBV
with no surgical deaths; 5 pts remain in stable condition awaiting surgery;
3 pts required shunt placement 9-66 days post-PBV; 1 pt died due to other
congenital anomalies.
Conclusions: Pulmonary balloon valvuloplasty promotes growth of the PAs
and PYA in infants with TOF and small PAs, offering a safe and effective alter-
native palliation for infants who are not yet candidates for complete repair.
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1722-1 I High Dose Dobutamine Echocardlography Detects
Myocardial Viability and Ischemia in Coronary
Cardiomyopathy
Stephen J. Lewis, Stephen G. Sawada, Samer Khouri. Mark O'Shaughnessy,
Judy Foltz. John R. Bates, Douglas S. Segar, Thomas Ryan, Gary D. Hutchins,
Harvey Feigenbaum. Indiana University School of Medicine, Indianapolis. IN
Augmentation of wall motion during low dose (~1 0 meg/kg/min) dobutamine
infusion has been utilized to detect myocardial viability in patients with is-
chemic cardiomyopathy. The utility of high dose (30-50 mcglkg/min) dobu-
tamine infusion to detect viable and compromised myocardium has not been
described. Thirty-three patients with ischemic cardiomyopathy (mean EF of
0.33 ± 0.084) had low and high dose dobutamine echocardiograms and
positron emission tomography (PET) using N-13 ammonia (NH3) and fluo-
rodeoxyglucose (FOG). Left ventricular wall motion, NH3 and FOG uptake
were scored using a 16 segment model. Of 490 interpretable segments, 321
(66%)were abnormal at rest. At low dose 85 (27%) segments augmented of
which 80 (94%) were viable by PET. In 15 patients. an additional 32 (10%)
abnormal segments augmented at high dose. PET viability was noted in
29 (91 %) of these segments. In 18 of 33 patients (55%), 38 segments had
stress induced wall motion abnormalities at high dose. Of the 38 segments,
37 197%) were viable by PET. Angiography showed 34 of these 38 (89%)
segments were supplied by an obstructed coronary artery (:';:50% diameter
stenosis). Conclusions: 1) The use of higher doses increases the sensitivity of
DE to detect viable myocardium. 2) Deterioration of wall motion at peak indi-
cates viable but compromised myocardium supplied by an obstructed coro-
nary artery.
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1722-21 Predicting Viability and Functional Recovery with
Dobutamine Echocardiography and Positron
Emission Tomography
Stephen J. Lewis, Stephen G. Sawada, John R. Bates, Judy Foltz. Douglas
S. Segar. Thomas Ryan. Gary D. Hutchins, Harvey Feigenbaum. Indiana University,
Indianapolis, iN
Positron emission tomography (PET) is considered the gold standard for de-
tecting myocardial viability. Unfortunately, PET is limited by availability and
cost. Dobutamine echocardiography (DE) may be a cost effective and more
available method of detecting viability. This report compared DE with PET in
33 patients (ptsl with advanced coronary disease using a 16 segment model
for left ventricular wall motion and uptake of fluorodeoxyglucose (FOG). PET
viability was defined as normal or mildly reduced uptake of FOG. DE viability
was defined as preserved wall motion at rest or augmentation during DE. PET
showed evidence of viability in 93% (157/169) of segments with normal rest
wall motion, 85% (62/731 of mildly hypokinetic segments and 93% (68/73) of
severely hypokinetic segments. DE and PET were concordant in only 41 %
(71/175) of akinetic segments (46 nonviable and 25 viable). To investigate
this discordance we evaluated follow up echocardiograms (:,;:four weeks)
after coronary bypass surgery in 8 pts with 36 akinetic segments at rest.
The ability of PET and DE to predict functional recovery of wall motion is as
shown:
(+)PV HPV Sens Spec
PET 044 0.85 0.85 044
DE 0.60 0.73 046 083
PV = predictive value
